Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality.

MLA

Schunk, Stefan J., et al. “Genetically Determined NLRP3 Inflammasome Activation Associates with Systemic Inflammation and Cardiovascular Mortality.” European Heart Journal, vol. 42, no. 18, May 2021, pp. 1742–56. EBSCOhost, https://doi.org/10.1093/eurheartj/ehab107.

APA

Schunk, S. J., Kleber, M. E., März, W., Pang, S., Zewinger, S., Triem, S., Ege, P., Reichert, M. C., Krawczyk, M., Weber, S. N., Jaumann, I., Schmit, D., Sarakpi, T., Wagenpfeil, S., Kramann, R., Boerwinkle, E., Ballantyne, C. M., Grove, M. L., Tragante, V., … Speer, T. (2021). Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality. European Heart Journal, 42(18), 1742–1756. https://doi.org/10.1093/eurheartj/ehab107

Chicago

Schunk, Stefan J, Marcus E Kleber, Winfried März, Shichao Pang, Stephen Zewinger, Sarah Triem, Philipp Ege, et al. 2021. “Genetically Determined NLRP3 Inflammasome Activation Associates with Systemic Inflammation and Cardiovascular Mortality.” European Heart Journal 42 (18): 1742–56. doi:10.1093/eurheartj/ehab107.